Registered Kenya · PPB

TASALINE 3% SOLUTION FOR INJECTION / INFUSION

SODIUM CHLORIDE 3%

H2022/CTD10670/24207 3% GENERIC/BIOSIMILARS

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2022/CTD10670/24207
Registration date
-
Expiry date
2028 September 26
Status
Registered
Active ingredient
SODIUM CHLORIDE 3%
Dosage form
3%
Strength
-
Pack size
1. 10ML OF THE PRODUCT (TASALINE 3% SOLUTION FOR INFUSION/INJECTION) IS FILLED IN A 10ML TYPE 1 GLASS AMPOULE. 5 AMPOULES ARE BLISTER PACKED. 1 OR 2 SUCH BLISTER PACKS ARE PACKED IN AN OUTER CARTON WITH LEAFLET. 100ML OF THE PRODUCT (TASALINE 3%
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Tasa Pharma
Applicant / LTR
TASA PHARMA LIMITED
Country of origin
LOCAL
Manufacturer location
MV6R+FP, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:23:05 · updated 2026-09-18 02:20:54

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.

Rwanda 4 products